QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
Free Trial
OTCMKTS:EMMA

Emmaus Life Sciences (EMMA) Stock Price, News & Analysis

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free EMMA Stock Alerts
$0.11
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.11
▼
$0.11
50-Day Range
$0.09
▼
$0.13
52-Week Range
$0.05
▼
$0.35
Volume
N/A
Average Volume
2,694 shs
Market Capitalization
$7.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest
EMMA stock logo

About Emmaus Life Sciences Stock (OTCMKTS:EMMA)

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.

EMMA Stock Price History

EMMA Stock News Headlines

April 17, 2024 | msn.com
District 11 wrestling: Kinney, Fanelli, Smith earn Scholar-Athlete awards
April 15, 2024 | finance.yahoo.com
Emmaus Life Sciences Reports Delayed Filing of Annual Report
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
April 10, 2024 | chicago.suntimes.com
The Museum of Science and Industry closed for mysterious reasons last week. Here’s why
April 10, 2024 | investing.com
Emmaus Life Sciences Inc (EMMA)
April 4, 2024 | msn.com
Peabody Museum Review: Smearing Science
March 27, 2024 | wsj.com
Emmaus Life Sciences Inc.
February 24, 2024 | msn.com
Homeless charity seeks volunteers to help with eBay operations
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
February 23, 2024 | msn.com
Discovery World named one of the best science museums in USA Today's 10Best Readers' Choice Awards
February 22, 2024 | msn.com
Texas Tech University Health Sciences Center announces Simulation Program reaccreditation
February 18, 2024 | abcnews.go.com
Saving democracy is central to Biden's campaign. Will it resonate with voters?
February 2, 2024 | finance.yahoo.com
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
February 1, 2024 | msn.com
Science Museum of Western Virginia announces grand opening of ‘The Eye’
January 18, 2024 | msn.com
Emmaus wrestlers roll their way over “flat” Freedom
January 17, 2024 | news.yahoo.com
Transgender row at Science Museum over claims reworked exhibit is 'even more insidious'
January 12, 2024 | msn.com
Biden says Austin still has his confidence, but not revealing hospitalization was lapse in judgment
January 8, 2024 | msn.com
Denver Museum of Nature & Science gets makeover with East Wing renovation project
January 4, 2024 | sfgate.com
A local guide to science museums near San Francisco
January 4, 2024 | msn.com
Science Museum of Minnesota receives largest gift in organization's history
November 17, 2023 | msn.com
The Museum of Illusions in Philadelphia meets science with immersive fun
November 14, 2023 | cbsnews.com
New exhibit at the Academy of Natural Sciences takes you back millions of years into history
November 14, 2023 | finanznachrichten.de
Emmaus Life Sciences, Inc.: Emmaus Life Sciences Reports Q3 2023 Financial Results
November 14, 2023 | msn.com
Emmaus Life Sciences GAAP EPS of -$0.01, revenue of $5M
November 14, 2023 | finance.yahoo.com
Emmaus Life Sciences Reports Q3 2023 Financial Results
November 10, 2023 | msn.com
Seattle nonprofit wants to help all students love math, using school programs and in-person exhibits
November 10, 2023 | msn.com
Best Museums for Kids in Philly: Children’s Museums and Family-Friendly Museums
See More Headlines
Receive EMMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:EMMA
CUSIP
N/A
CIK
822370
Web
www.emmausmedical.com
Phone
(310) 214-0065
Fax
866-294-2611
Employees
54
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,620,000.00
Net Margins
-16.66%
Pretax Margin
-16.42%
Return on Equity
N/A
Return on Assets
-9.73%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.15
Quick Ratio
0.12

Sales & Book Value

Annual Sales
$18.39 million
Price / Sales
0.38
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.69) per share
Price / Book
-0.16

Miscellaneous

Outstanding Shares
61,850,000
Free Float
40,200,000
Market Cap
$7.04 million
Optionable
Not Optionable
Beta
1.61
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Willis C. Lee M.S. (Age 64)
    Co-President, COO & Chairman of the Board
    Comp: $240k
  • Mr. Yasushi Nagasaki CPA (Age 57)
    CPA, Chief Financial Officer
    Comp: $250k
  • Mr. George Sekulich (Age 58)
    Co-President, Chief Commercial Officer & Director
  • Mr. Dale E. Short J.D.
    Legal Consultant & Corporate Secretary
  • Dr. Charles W. Stark Pharm.D (Age 69)
    Pharm.D., Senior Vice President of Medical Affairs, Clinical, Regulatory
  • Mr. Kurt H. Kruger M.B.A. (Age 69)
    M.S., Consultant
    Comp: $300.02k

Key Competitors

View All Competitors

EMMA Stock Analysis - Frequently Asked Questions

How have EMMA shares performed in 2024?

Emmaus Life Sciences' stock was trading at $0.1001 at the beginning of 2024. Since then, EMMA shares have increased by 13.6% and is now trading at $0.1138.
View the best growth stocks for 2024 here.

Are investors shorting Emmaus Life Sciences?

Emmaus Life Sciences saw a decline in short interest in March. As of March 31st, there was short interest totaling 800 shares, a decline of 89.5% from the March 15th total of 7,600 shares. Based on an average trading volume of 12,400 shares, the short-interest ratio is currently 0.1 days.
View Emmaus Life Sciences' Short Interest.

How do I buy shares of Emmaus Life Sciences?

Shares of EMMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EMMA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The “Perfect Storm” for Gold
Gold Safe Exchange
Strange new buyer driving up gold
Stansberry Research
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
SHOCKING Crypto Leak…
Crypto 101 Media
Top 5 AI Stocks to Buy for 2024
Market Moving Trends